Zynext Ventures Invests in Agenus Inc. to Accelerate Development of Immunotherapy Program

Zynext Ventures, the venture capital arm of Zydus Lifesciences, has invested in Agenus Inc., a US-based immuno-oncology company, to support the development and expansion of Agenus' immunotherapy program.